Publicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (11)

2023

  1. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2016

  1. Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome

    Pharmacology Research and Perspectives, Vol. 4, Núm. 2

2015

  1. Efficient in vivo antitumor effect of an immunotoxin based on ribotoxin α-sarcin in nude mice bearing human colorectal cancer xenografts

    SpringerPlus, Vol. 4, Núm. 1

2012

  1. Functional characterization of MODY2 mutations highlights the importance of the fine-tuning of glucokinase and its role in glucose sensing

    PLoS ONE, Vol. 7, Núm. 1

2008

  1. Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas

    Cancer Research, Vol. 68, Núm. 12, pp. 4541-4550

2007

  1. Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis

    Journal of Biological Chemistry, Vol. 282, Núm. 9, pp. 6854-6862

2006

  1. A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells

    Molecular Pharmacology, Vol. 70, Núm. 1, pp. 51-59

  2. Functional characterization of human mesenchymal stern cells that maintain osteochondral fates

    Journal of Cellular Biochemistry, Vol. 98, Núm. 6, pp. 1457-1470

2005

  1. Interleukin 12 (IL12B) and interleukin 12 receptor (IL12RB1) gene polymorphisms in rheumatoid arthritis

    Human Immunology, Vol. 66, Núm. 6, pp. 710-714

2004

  1. Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas

    Cancer Research, Vol. 64, Núm. 16, pp. 5617-5623